Note: Ingredients listed on restricted chemical lists
EC/CAS
201-180-5/79-14-1
Name of the chemical
Glycolic acid
Concentration
N/A
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2024-06-02
Product name
GlySmart
Product Synonyms
Not Available
1.2.1 Relevant identified uses
Personal care 1.3 & 1.4 Supplier and Emergency contact details
Emergency telephone
800-424-9300
Icons in SDS
Company Information
company name
CROSSCHEM LIMITED
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H314, H332
Hazard statements
Code
Statements
H314
Causes severe skin burns and eye damage
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
H332 Harmful if inhaled (Category 4) H314 Causes severe skin burns and eye damage (Category 1B)
Signal word
Danger
Hazard statements
H332 Harmful if inhaled H314 Causes severe skin burns and eye damage
Precautionary statements
P260 Do not breathe dusts or mists P264 Wash skin thoroughly after handling P271 Use only outdoors or in a well-ventilated area P280 Wear protective gloves / protective clothing / eye protection / face protection P301+P330+P331 IF SWALLOWED: Rinse mouth. Do NOT induce vomiting P303+P361+P353 IF ON SKIN (or hair): Remove / take off immediately all contaminated clothing. Rinse skin with water / shower P304+P340+310 IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. Immediately Call a POISON CENTER or doctor P305+P351 +P338+310 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Call a POISON CENTER or doctor P363 Wash contaminated clothing before reuse P405 Store locked up P501 Dispose of contents / container to an approved waste disposal plant
2.3 Other hazards
Endocrine Chemicals The substance is not included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.